Literature DB >> 1358156

Flow cytometric characterisation of proliferating cell nuclear antigen using the monoclonal antibody PC10.

G D Wilson1, R S Camplejohn, C A Martindale, A Brock, D P Lane, D M Barnes.   

Abstract

Anti-PCNA antibodies have aroused considerable interest recently as potential immunohistochemical markers of proliferation for use on clinical samples. PC10 is a monoclonal antibody which has been shown to recognise its epitope on formalin-fixed, paraffin-embedded, archival material. However, whilst PC10 gives the expected labelling pattern for growth fraction in normal tissues and some tumours, discrepant results have been obtained, for example, in carcinoma of the breast. By means of flow cytometry, we have attempted to characterise the different staining patterns that can be obtained with PC10. Intact fixed cells from proliferative mammalian cultures show 100% labelling, consistent with a growth fraction estimate. In contrast, detergent-extracted nuclei show S-phase specific staining. Nuclei extracted by treatment of fixed cells with pepsin show a different staining pattern again, with many G1 cells weakly stained and staining intensity increasing through S-phase into G2. The results demonstrate that multiparametric flow cytometry can define the cell populations which label with proliferation-related antibodies, such as PC10, under a variety of experimental conditions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1358156     DOI: 10.1016/0959-8049(92)90250-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  3 in total

1.  Comparison of three cell cycle associated antigens as markers of proliferative activity and prognosis in breast carcinoma.

Authors:  C E Gillett; D M Barnes; R S Camplejohn
Journal:  J Clin Pathol       Date:  1993-12       Impact factor: 3.411

2.  Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells.

Authors:  R S Camplejohn; A Brock; D M Barnes; C Gillett; B Raikundalia; H Kreipe; M R Parwaresch
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

3.  A possible screening test for inherited p53-related defects based on the apoptotic response of peripheral blood lymphocytes to DNA damage.

Authors:  R S Camplejohn; P Perry; S V Hodgson; G Turner; A Williams; C Upton; C MacGeoch; S Mohammed; D M Barnes
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.